The knockdown or pharmacological inhibition of Nox4 activity abolishes tumor-induced cachexia in mice, suggesting that targeting the SIRT1-Nox4 axis in muscles mitigates cachexia in pancreatic cancer [35]. The gene discussed is NOX4; the disease is familial pancreatic carcinoma.